Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
30,964,332
-
Share change
-
+1,196,069
-
Total reported value
-
$100,942,626
-
Put/Call ratio
-
25%
-
Price per share
-
$3.26
-
Number of holders
-
98
-
Value change
-
-$1,236,684
-
Number of buys
-
56
-
Number of sells
-
45
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2024
As of 30 Jun 2024 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,964,332 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Frazier Life Sciences Management, L.P., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GREAT POINT PARTNERS LLC, Eversept Partners, LP, Athyrium Capital Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 98 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.